Statement of Changes in Beneficial Ownership (4)
20 March 2021 - 8:25AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Bamforth Mark R |
2. Issuer Name and Ticker or Trading Symbol
Avid Bioservices, Inc.
[
CDMO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
2642 MICHELLE DRIVE, SUITE 200 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/17/2021 |
(Street)
TUSTIN, CA 92780
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.001 par value | 3/17/2021 | | S(1) | | 100000 | D | $18.18 (2) | 0 | D | |
Common Stock, $0.001 par value | 3/17/2021 | | S(1) | | 26000 | D | $18.18 (2) | 0 | I | By Self as co-trustee of the Mark R. Bamforth Family Trust |
Common Stock, $0.001 par value | 3/17/2021 | | P(1) | | 126000 | A | $18.18 (2) | 126000 | I | By Mark R. Bamforth Irrevocable Trust dated April 2, 2015 (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | Represents a private sale between the reporting person and the Mark R. Bamforth Irrevocable Trust dated April 2, 2015, for which the reporting person's wife and children serve as co-trustees and are beneficiaries of the Trust. |
(2) | The value of the shares transferred to the Mark R. Bamforth Irrevocable Trust dated April 2, 2015 was measured by the closing price of the Issuer's common stock on March 17, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Bamforth Mark R 2642 MICHELLE DRIVE, SUITE 200 TUSTIN, CA 92780 | X |
|
|
|
Signatures
|
/s/ Stephen Hedberg, by Power of Attorney for Mark R. Bamforth | | 3/19/2021 |
**Signature of Reporting Person | Date |
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2024 to May 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From May 2023 to May 2024